James Kihara - Net Worth and Insider Trading
James Kihara Net Worth
The estimated net worth of James Kihara is at least $215,550 dollars as of 2024-11-05. James Kihara is the PRINCIPAL ACCOUNTING OFFICER of ACADIA Pharmaceuticals Inc and owns about 14,370 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $215,550. Details can be seen in James Kihara's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Kihara has not made any transactions after 2024-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Kihara
James Kihara Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Kihara owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of James Kihara’s form 4 insider trades.
Insider Ownership Summary of James Kihara
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-05-02 | Principal Accounting Officer |
James Kihara Latest Holdings Summary
James Kihara currently owns a total of 1 stock. James Kihara owns 14,370 shares of ACADIA Pharmaceuticals Inc (ACAD) as of May 2, 2024, with a value of $215,550.
Latest Holdings of James Kihara
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-05-02 | 14,370 | 15.00 | 215,550 |
Holding Weightings of James Kihara
James Kihara Form 4 Trading Tracker
According to the SEC Form 4 filings, James Kihara has made a total of 13 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 1,326 shares on May 2, 2024, which brought James Kihara around $22,462.
Insider Trading History of James Kihara
- 1
James Kihara Trading Performance
James Kihara Ownership Network
Ownership Network List of James Kihara
Ownership Network Relation of James Kihara
James Kihara Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
James Kihara is the Principal Accounting Officer of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, James Kihara made 8 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 17,522. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .
In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
James Kihara Mailing Address
Above is the net worth, insider trading, and ownership report for James Kihara. You might contact James Kihara via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
